1997
DOI: 10.4049/jimmunol.159.5.2222
|View full text |Cite
|
Sign up to set email alerts
|

Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice.

Abstract: We have recently shown that Flt3 ligand administration dramatically increases dendritic cell (DC) numbers in various mouse tissues. This has enabled the identification of distinct mature DC subpopulations. These have been designated: population C (CD11c(bright) CD11b(bright)), D (CD11c(bright) CD11b(dull)), and E (CD11c(bright) CD11b(negative)) This report demonstrates that the mature DC subsets (C, D, and E) from Flt3 ligand-treated mice differ with respect to phenotype, geographic localization, and function.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1999
1999
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 386 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Systemic application of Flt3L for several days promotes preDC proliferation in the BM. 23 Similarly, a general paucity of cDCs leads to elevated systemic Flt3L levels, which, in a progenitor-progeny feedback mechanism, increases the preDC output from the BM. 24 However, this feedback mechanism only adapts the quantity of cDCs and not the developmental stage of an individual cell in the tissue.…”
Section: Resultsmentioning
confidence: 99%
“…Systemic application of Flt3L for several days promotes preDC proliferation in the BM. 23 Similarly, a general paucity of cDCs leads to elevated systemic Flt3L levels, which, in a progenitor-progeny feedback mechanism, increases the preDC output from the BM. 24 However, this feedback mechanism only adapts the quantity of cDCs and not the developmental stage of an individual cell in the tissue.…”
Section: Resultsmentioning
confidence: 99%
“…Among these findings is the key developmental signal for cDCs during hematopoiesis through the engagement of fms-like tyrosine kinase 3 (FLT3) by its ligand FLT3L and downstream activation of STAT3 [9]. Exogenous injection of FLT3L increases abundance of cDCs in vivo but there have not been reports of pathogenicity associated with high amounts of FLT3L [9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%